
    
      This randomized controlled trial will enroll patients with vestibular migraine from the First
      Affiliated Hospital of Jiaxing University. All participants will be randomly assigned to two
      groups. Participants will receive acupuncture in the treatment group, while participants in
      the control group will be treated by venlafaxine. All treatments will be given for 8 weeks.
      The primary outcome measures are change in vertigo/migraine days and vertigo/migraine
      attacks, vertigo severity, and migraine intensity per 4 weeks from baseline. The secondary
      outcome measures are change in dosage of rescue medication, anxiety level，depression
      level，and quality of life per 4 weeks from baseline.
    
  